Antitumour necrosis factor alpha treatment in Crohn's disease: long-term efficacy, side effects and need for surgery

Lerang, F; Holst, R; Henriksen, M; Wahlberg, H; Jelsness-Jorgensen, LP

Lerang, F (通讯作者),Ostfold Hosp Trust, Dept Gastroenterol, Kalnesveien 300, N-1714 Gralum, Norway.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022; 57 (8): 921

Abstract

Objectives To examine the long-term efficacy and side effects of antitumour necrosis factor alpha (anti-TNF) therapy in patients with Crohn's disease ......

Full Text Link